simvastatin has been researched along with Thrombophilia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asensio-Sánchez, VM; Castresana-Jauregui, I; Hernaez-Ortega, MC | 1 |
Altmann, P; Armitage, J; Baigent, C; Baxter, A; Cairns, HS; Collins, R; Foley, RN; Frighi, V; Kourellias, K; Landray, M; Leaper, C; Ratcliffe, PJ; Rogerson, M; Scoble, JE; Tomson, CR; Warwick, G; Wheeler, DC | 1 |
Huber, K; Kaun, C; Kopp, CW; Minar, E; Pleiner, J; Seidinger, D; Speidl, WS; Steiner, S; Wojta, J; Wolzt, M; Zorn, G | 1 |
Dorner, GT; Joukhadar, C; Klein, N; Prinz, M; Schmetterer, L; Schrolnberger, C; Vukovich, T; Wolzt, M | 1 |
Hryszko, T; Małyszko, J; Małyszko, JS; Myśliwiec, M | 1 |
3 trial(s) available for simvastatin and Thrombophilia
Article | Year |
---|---|
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease.
Topics: Adult; Aged; Alanine Transaminase; Aspirin; Cardiovascular Diseases; Cholesterol, LDL; Chronic Disease; Creatine Kinase; Creatine Kinase, MM Form; Creatinine; Diabetic Nephropathies; Disease Progression; Feasibility Studies; Female; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Isoenzymes; Kidney Diseases; Kidney Transplantation; Lipids; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Renal Dialysis; Renal Replacement Therapy; Simvastatin; Single-Blind Method; Thrombophilia; Treatment Outcome | 2005 |
Simvastatin blunts endotoxin-induced tissue factor in vivo.
Topics: Adult; Biomarkers; Endotoxins; Gene Expression Regulation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Monocytes; Platelet Activation; Premedication; Simvastatin; Thrombophilia; Thromboplastin | 2005 |
Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia.
Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; C-Reactive Protein; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Inflammation; Lipids; Male; Middle Aged; Pravastatin; Pyrroles; Simvastatin; Therapeutic Equivalency; Thrombophilia; Treatment Outcome | 2001 |
2 other study(ies) available for simvastatin and Thrombophilia
Article | Year |
---|---|
[Central retinal vein occlusion as the first symptom of ovarian cancer].
Topics: Carcinoma; Fatal Outcome; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Middle Aged; Ovarian Neoplasms; Paraneoplastic Syndromes; Peritoneal Neoplasms; Protein S; Retinal Vein; Retinal Vein Occlusion; Simvastatin; Thrombophilia | 2013 |
Simvastain affects TAFI and thrombomodulin in CAPD patients.
Topics: Adult; Anticholesteremic Agents; Biomarkers; Blood Proteins; Carboxypeptidase B2; Cholesterol, LDL; Drug Administration Schedule; Drug Evaluation; Female; Fibrin Fibrinogen Degradation Products; Humans; Hypercholesterolemia; Kidney Failure, Chronic; Lipids; Lipoproteins; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Simvastatin; Thrombomodulin; Thrombophilia | 2001 |